Skip to main content
. 2022 Feb 28;13(5):1540–1552. doi: 10.7150/jca.60124

Table 2.

Correlations between miR-421 expression and clinical characteristics in lung adenocarcinoma patients (n=73)

Variable No. of cases miR-421 expression P
low high
Total 73 37 36
Age (years)
≤60 44 23 21 0.7382
>60 29 14 15
Sex
Male 36 14 22 0.0468
Female 37 23 14
Smoking
No 43 26 17 0.0454
Yes 30 11 19
TNM stage
I/II 53 29 24 0.2620
III 20 8 12
Differentiation
Poor/moderate 67 31 36 0.012
Good 6 6 0
5-year survival
No 26 8 18 0.0114
Yes 47 29 18